Literature DB >> 25865259

Brief Report: Factors Released by Megakaryocytes Thrombin Cleave Osteopontin to Negatively Regulate Hematopoietic Stem Cells.

Melonie J Storan1, Shen Y Heazlewood1,2, Chad K Heazlewood1,2, David N Haylock1,2, Warren S Alexander3,4, Rebecca J Neaves1,5, Ana Oteiza6, Susan K Nilsson1,2.   

Abstract

Factor V (FV) and factor X (FX) activate and complex to form prothrombinase which subsequently cleaves prothrombin (PT), converting it to active thrombin. Thrombin cleaved osteopontin (tcOPN) contains a cryptic binding site for α4 β1 and α9 β1 integrins. We have previously shown that hematopoietic stem cells (HSC) bind to tcOPN via this site resulting in a decrease in their proliferation and differentiation. Therefore, tcOPN and the factors required for its generation are important components of the HSC niche. Herein we show mature megakaryocytes (MM, ≥8N) contain FV, FX, and PT mRNA and protein. Furthermore, we show 8N, 16N, 32N, and 64N MM all release the required factors to enable thrombin cleavage of OPN. Importantly, mice devoid of the myeloproliferative leukemia protein (Mpl), c-Mpl(-/-) mice, contain only approximately 10% of normal megakaryocyte numbers, showed significantly reduced FX and tcOPN protein levels in endosteal bone marrow (BM). In addition, WT hematopoietic progenitors and HSC showed reduced homing to the BM of c-Mpl(-/-) mice. This is the first report identifying MM as a key cellular component in the production of tcOPN in situ, allowing the BM microenvironment to self regulate HSC biology via tcOPN.
© 2015 AlphaMed Press.

Entities:  

Keywords:  Bone marrow; Hematopoietic stem cells; Megakaryocytes; Niche/microenvironment; Osteopontin; Thrombin

Mesh:

Substances:

Year:  2015        PMID: 25865259     DOI: 10.1002/stem.2038

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  9 in total

1.  Hemostasis keeps the stem cell niche in order.

Authors:  Wolfram Ruf
Journal:  Blood       Date:  2016-08-25       Impact factor: 22.113

2.  Megakaryocyte and Osteoblast Interactions Modulate Bone Mass and Hematopoiesis.

Authors:  Marta B Alvarez; LinLin Xu; Paul J Childress; Kevin A Maupin; Safa F Mohamad; Brahmananda R Chitteti; Evan Himes; David J Olivos; Ying-Hua Cheng; Simon J Conway; Edward F Srour; Melissa A Kacena
Journal:  Stem Cells Dev       Date:  2018-05-15       Impact factor: 3.272

3.  Activation of JAK/STAT Signaling in Megakaryocytes Sustains Myeloproliferation In Vivo.

Authors:  Brittany Woods; Wei Chen; Sophia Chiu; Christian Marinaccio; Chunling Fu; Lilly Gu; Marinka Bulic; Qiong Yang; Anouar Zouak; Shengxian Jia; Praveen Kumar Suraneni; Kailin Xu; Ross L Levine; John D Crispino; Qiang Jeremy Wen
Journal:  Clin Cancer Res       Date:  2019-06-19       Impact factor: 12.531

4.  Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.

Authors:  Sophia R Balderman; Allison J Li; Corey M Hoffman; Benjamin J Frisch; Alexandra N Goodman; Mark W LaMere; Mary A Georger; Andrew G Evans; Jane L Liesveld; Michael W Becker; Laura M Calvi
Journal:  Blood       Date:  2015-12-04       Impact factor: 22.113

Review 5.  Extravascular coagulation in hematopoietic stem and progenitor cell regulation.

Authors:  T Son Nguyen; Tsvee Lapidot; Wolfram Ruf
Journal:  Blood       Date:  2018-06-04       Impact factor: 22.113

6.  Osteopontin deletion drives hematopoietic stem cell mobilization to the liver and increases hepatic iron contributing to alcoholic liver disease.

Authors:  Fernando Magdaleno; Xiaodong Ge; Holger Fey; Yongke Lu; Harriet Gaskell; Chuck C Blajszczak; Costica Aloman; M Isabel Fiel; Natalia Nieto
Journal:  Hepatol Commun       Date:  2017-11-12

7.  Osteopontin is An Important Regulative Component of the Fetal Bone Marrow Hematopoietic Stem Cell Niche.

Authors:  Huimin Cao; Benjamin Cao; Chad K Heazlewood; Melanie Domingues; Xuan Sun; Emmanuel Debele; Narelle E McGregor; Natalie A Sims; Shen Y Heazlewood; Susan K Nilsson
Journal:  Cells       Date:  2019-08-27       Impact factor: 6.600

8.  Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology.

Authors:  Moran Amit; Tongxin Xie; Frederico O Gleber-Netto; Patrick J Hunt; Gautam U Mehta; Diana Bell; Deborah A Silverman; Ismail Yaman; Yi Ye; Jared K Burks; Gregory N Fuller; Paul W Gidley; Marc-Elie Nader; Shaan M Raza; Franco DeMonte
Journal:  J Exp Clin Cancer Res       Date:  2022-10-04

9.  Therapeutic targeting and rapid mobilization of endosteal HSC using a small molecule integrin antagonist.

Authors:  Benjamin Cao; Zhen Zhang; Jochen Grassinger; Brenda Williams; Chad K Heazlewood; Quentin I Churches; Simon A James; Songhui Li; Thalia Papayannopoulou; Susan K Nilsson
Journal:  Nat Commun       Date:  2016-03-15       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.